Section Arrow
RVTY.NYSE
- Revvity
Quotes are at least 15-min delayed:2026/04/28 23:07 EDT
Regular Hours
Last
 85.18
-1.62 (-1.87%)
Day High 
87.24 
Prev. Close
86.8 
1-M High
97.07 
Volume 
1.11M 
Bid
83.82
Ask
86.78
Day Low
84.69 
Open
86.94 
1-M Low
82.7913 
Market Cap 
9.70B 
Currency 美元 
P/E 42.14 
%Yield 0.33 
10-SMA 91.22 
20-SMA 90.04 
50-SMA 91.28 
52-W High 118.2999 
52-W Low 81.36 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
2.07/6.21
Enterprise Value
12.48B
Balance Sheet
Book Value Per Share
64.85
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
3.78B
Operating Revenue Per Share
25.01
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
QGENQiagen NV34.02-4.07-10.69%18.65PE
QUCYMainz Biomed N.V.0.5018-0.038-7.04%-- 
DHRDanaher Corp178.98-1.64-0.91%35PE
NEONeoGenomics9.02+0.41+4.76%-- 
BIAFbioAffinity Technologies Inc2.66+0.45+20.36%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.